BONE AND RENAL SAFETY ARE IMPROVED IN CHRONIC HBV PATIENTS 1 YEAR AFTER SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) FROM TENOFOVIR DISOPROXIL FUMARATE (TDF)


Chan H. L. Y., Seto W. K., Buti M., Izumi N., Lim Y., Kao J., ...More

International Digestive Disease Forum (IDDF), Hong Kong, Hong Kong, 8 - 09 June 2019, vol.68, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 68
  • Doi Number: 10.1136/gutjnl-2019-iddfabstracts.277
  • City: Hong Kong
  • Country: Hong Kong
  • Istanbul University-Cerrahpasa Affiliated: No